Literature DB >> 10376987

Clinico-pathological and treatment-related factors influencing survival in parotid cancer.

A G Renehan1, E N Gleave, N J Slevin, M McGurk.   

Abstract

One hundred and three patients with primary parotid cancer treated surgically at the Christie Hospital, Manchester (1952-1992), were analysed to assess the influence on survival of prognostic and treatment-related factors. Thirty-seven patients were treated by surgery alone (SG), 66 received post-operative radiation (SG+RT). Median follow-up was 12 years, minimum 5 years. The 10-year disease-specific survival rates for stage I, II and III/IV were 96%, 61% and 17% respectively (P < 0.0001). The various histological types segregated into three survival patterns: low-, intermediate-and high-grade with 10-year survival rates of 93%, 41% and 50% respectively (P < 0.0001). On multivariate analysis, the factors influencing risk of cancer death in order of importance were: tumour size > 4 cm (P < 0.001), presence of nodes (P = 0.001), histology of adenoid cystic carcinoma (P = 0.01), high-tumour grade (P = 0.02) and perineural involvement (P = 0.01). Neither the extent of surgery nor the operator influenced outcome. Overall, adjuvant RT significantly reduced locoregional recurrence (SG+RT 15% vs SG 43%; P = 0.002) but not survival, although on subanalysis, there was a trend to improved survival with large cancers and high-grade tumours. Long-term survival is determined primarily by tumour characteristics, namely clinical stage and grade. Post-operative RT contributes significantly to locoregional control and probably confers some survival advantage in high-risk patients.

Entities:  

Mesh:

Year:  1999        PMID: 10376987      PMCID: PMC2362357          DOI: 10.1038/sj.bjc.6990501

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology.

Authors:  K T Robbins; J E Medina; G T Wolfe; P A Levine; R B Sessions; C W Pruet
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-06

2.  Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas.

Authors:  M McGurk; A Renehan; E N Gleave; B D Hancock
Journal:  Br J Surg       Date:  1996-12       Impact factor: 6.939

3.  Carcinoma of major salivary glands. Recent trends.

Authors:  R H Spiro; J Armstrong; L Harrison; N L Geller; S Y Lin; E W Strong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-03

4.  Salivary neoplasms: overview of a 35-year experience with 2,807 patients.

Authors:  R H Spiro
Journal:  Head Neck Surg       Date:  1986 Jan-Feb

5.  An analysis of radiotherapy in the management of 104 patients with parotid carcinoma.

Authors:  A J Sykes; J P Logue; N J Slevin; N K Gupta
Journal:  Clin Oncol (R Coll Radiol)       Date:  1995       Impact factor: 4.126

6.  Malignant parotid tumors. Prognostic factors and optimum treatment.

Authors:  C Theriault; P J Fitzpatrick
Journal:  Am J Clin Oncol       Date:  1986-12       Impact factor: 2.339

7.  Carcinoma of the parotid gland. Analysis of treatment results and patterns of failure after combined surgery and radiation therapy.

Authors:  I J Spiro; C C Wang; W W Montgomery
Journal:  Cancer       Date:  1993-05-01       Impact factor: 6.860

8.  Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy.

Authors:  J G Armstrong; L B Harrison; R H Spiro; D E Fass; E W Strong; Z Y Fuks
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

9.  Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients.

Authors:  H Leverstein; J E van der Wal; R M Tiwari; H Tobi; I van der Waal; D M Mehta; G B Snow
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

10.  Primary parotid malignancies. A clinical and pathologic review.

Authors:  W J Kane; T V McCaffrey; K D Olsen; J E Lewis
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-03
View more
  30 in total

1.  [Rare malignant tumor of the parotid gland. Myoepithelial carcinoma].

Authors:  F Haubner; H G Gassner; F Eder; U Müller-Vogt
Journal:  HNO       Date:  2010-11       Impact factor: 1.284

2.  [Acute abdomen and carcinoma of the glandula parotis].

Authors:  J Schmutzhard; I Schwentner; J Krugmann; G M Sprinzl
Journal:  HNO       Date:  2006-08       Impact factor: 1.284

3.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

4.  Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.

Authors:  Safina Ali; Robert Bryant; Frank L Palmer; Monica DiLorenzo; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-03-06       Impact factor: 5.344

5.  Kaplan-Meier analysis of salivary gland tumors: prognosis and long-term survival.

Authors:  Yair Israel; Adi Rachmiel; Konstantin Gourevich; Rafael Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-11       Impact factor: 4.553

6.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

Review 7.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

8.  BCL-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients.

Authors:  Michael Genetzakis; Ilias P Gomatos; Anastasia N Georgiou; John Giotakis; Leonidas Manolopoulos; Kappaonstantina Papadimitriou; Helen Chra; Emmanuel Leandros; Christos Tsigris; Eleutherios A Ferekidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-27       Impact factor: 2.503

Review 9.  Cancer of the parotid gland: role of 7th nerve preservation.

Authors:  Jeffrey D Spiro; Ronald H Spiro
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

10.  [Prognostic value of immunohistochemistry in salivary gland cancer].

Authors:  T Ettl; S Schwarz; T Kühnel; P Stockmann; T E Reichert; O Driemel
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.